Professional Documents
Culture Documents
picture awaited!
Disease
Minimal change
disease
FSGS
Membranous
Comments
Most common in children usually
responds quickly to steroids
Cause is unknown in most cases, some
response to special treatment
Cause is often unknown, but may occur
with other diseases drugs and infections.
Most improve with time but some
nephropathy
MCGN
Diabetes
SLE
SLE
For other EdREN topics (including information on chronic renal failure, dialysis,
and transplantation) click here.
Medical staff and other healthcare workers may find the following pages useful:
Diagnosis
In addition to a physical examination and the assessment of family health history,
the following three tests are used to make a diagnosis:
Blood analysis
Urinalysis
Kidney biopsy
Blood analysis often shows high cholesterol levels and low albumin. BUN and
creatinine may or may not be elevated. If bun and creatinine are elevated the patient
has renal failure and the prognosis is worse.
Evaluation of the urine by a simple urine dipstick in the office can give preliminary
information on the amount of protein in the urine. However, this test is a qualitative
test. In order to determine the actual amount of protein in the urine, a 24-hour
quantitative test must be done, which indicates levels of protein and creatinine in the
urine. Often, a comparison of protein to creatinine based on a single sample is used
to determine 24-hour protein loss. This is helpful for quicker results or when the
patient cannot collect urine over 24 hours.
A closed kidney biopsy may be used to determine the underlying cause and extent of
disease with the exception of the following cases.
1. Children with NS most often have minimal change disease and respond well
2.
3.
Treatment
Nonspecific treatment of nephrotic syndrome is aimed at complications like
hypertension. Specific treatment addresses underlying causes, which are determined
by kidney biopsy.
Nonspecific Treatment
Controlling hypertension is essential in reducing proteinuria. This is accomplished
with angiotensin converting enzyme (ACE-1) inhibitors. ACE-1 inhibitors are the
preferred blood pressure lowering medication because they provided added
protection to the kidneys. These drugs interfere with the production of angiotensin II
(AII), a chemical (vasoactive) produced in the body. AII causes vascular constriction,
which increases blood pressure, including pressure in the glomeruli. This causes
scarring of the kidney and exacerbates proteinuria, which accelerates the loss of
renal function. ACE-1 inhibitors encourage circulation, lower blood pressure in the
body, and decrease pressure in the glomeruli. This decreases protein spillage and
helps to delay progressive scarring of the glomeruli.
Patients with hypertension benefit from ACE-1 inhibitors, as aggressive blood
pressure control is key to protecting the kidneys and the cardiovascular system. The
goal is to lower the systolic blood pressure below 130 and the diastolic below 80.
ACE-1 inhibitors cause a dry cough in approximately 8% of patients who take them.
ACE-1 inhibitors are given in the highest dose tolerable to ensure kidney protection.
If a patient develops a cough, a new class of drugs may be used, known as
angiotensin receptor blockers (ARB). ARBs work by blocking angiotensin receptors,
which blocks the effects of angiotensin after it is produced. They offer the same
kidney protection as ACE-1 inhibitors without causing cough. If tolerable, ARBs may
be combined with an ACE-1 inhibitor for added benefit.
Treating hypercholesterolemia (high cholesterol) typically involves medication and
proper diet.
It is generally considered healthy to eat one gram of protein daily for every kilogram
of body weight; physicians usually help their patients define a diet that is appropriate
for kidney health.
Specific Treatment
Specific treatment is given for the following underlying causes of nephrotic
syndrome:
Diabetes
Glomerular disease
Minimal change disease
Renal failure
Treating minimal change disease in children usually involves the use of diuretics
to reduce edema and a corticosteroid called prednisone (Liquid Pred), which usually
resolves proteinuria in a couple of weeks. Corticosteroids heal the ongoing damage
at the level of the glomerular basement membrane (i.e., they patch the holes that
are allowing the proteins to leak through).
About 30% of children treated with prednisone have no recurrence of disease,
roughly 20% relapse after several months, and the remaining 50% relapse a short
time after discontinuing the medication.
Prognosis
The outcome of NS varies and is largely dependent on the underlying cause. Some
patients may have a spontaneous recovery not requiring any specific therapy, while
others worsen despite aggressive, specific therapy.
Complications that can arise during treatment include atherosclerosis "hardening of
the arteries" and adverse reaction to medications such as steroids. Some severe side
effects that can occur with the use of steroids include osteoporosis, cataract
development, increased risk of infection, and diabetes.